SG Americas Securities
RLAY icon

SG Americas Securities’s Relay Therapeutics RLAY Stock Holding History

SG Americas Securities’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Sell
95,234
-102,301
-52% -$1.49M ﹤0.01% 1567
2026
Q1 		$1.97M Sell
197,535
-23,414
-11% -$209K ﹤0.01% 1404
2025
Q4 		$1.87M Buy
220,949
+189,004
+592% +$1.35M ﹤0.01% 1572
2025
Q3 		$167K Buy
31,945
+4,825
+18% +$18.4K ﹤0.01% 2844
2025
Q2 		$94K Sell
27,120
-36,502
-57% -$109K ﹤0.01% 2652
2025
Q1 		$167K Sell
63,622
-13,935
-18% -$54.6K ﹤0.01% 2665
2024
Q4 		$320K Buy
77,557
+22,473
+41% +$122K ﹤0.01% 1740
2024
Q3 		$390K Buy
+55,084
New +$412K ﹤0.01% 1916
2024
Q1 		– Sell
-91,973
Closed -$1.01M – 3367
2023
Q4 		$1.01M Buy
91,973
+53,559
+139% +$452K 0.01% 1019
2023
Q3 		$323K Buy
+38,414
New +$413K ﹤0.01% 2033
2023
Q1 		– Sell
-17,450
Closed -$261K – 3508
2022
Q4 		$261K Buy
17,450
+5,299
+44% +$101K ﹤0.01% 2028
2022
Q3 		$272K Sell
12,151
-71,713
-86% -$1.57M ﹤0.01% 2075
2022
Q2 		$1.41M Buy
83,864
+38,641
+85% +$828K 0.02% 999
2022
Q1 		$1.35M Sell
45,223
-2,552
-5% -$61.9K 0.01% 1207
2021
Q4 		$1.47M Sell
47,775
-42,965
-47% -$1.36M 0.01% 1348
2021
Q3 		$2.86M Buy
90,740
+62,351
+220% +$2.1M 0.01% 970
2021
Q2 		$1.04M Sell
28,389
-3,121
-10% -$103K ﹤0.01% 1536
2021
Q1 		$1.09M Buy
31,510
+8,006
+34% +$347K 0.01% 1475
2020
Q4 		$977K Buy
+23,504
New +$1.06M 0.01% 1548

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

SG Americas Securities's RLAY Position: Q2 2026 in Review

SG Americas Securities reduced its Relay Therapeutics (RLAY) stake by 52% in Q2 2026, selling an estimated $1.49M and leaving 95,234 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1567.

SG Americas Securities first reported a position in RLAY in Q4 2020 and has held it in 19 quarters since. The position peaked at $2.86M in Q3 2021. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • SG Americas Securities held 95,234 shares of Relay Therapeutics worth $1.78M as of Q2 2026.
  • SG Americas Securities sold 102,301 Relay Therapeutics shares in Q2 2026, an estimated $1.49M.
  • Relay Therapeutics made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1567 holding.
  • SG Americas Securities first reported a position in Relay Therapeutics in Q4 2020 and has held it in 19 quarters since.
  • SG Americas Securities's Relay Therapeutics position peaked at $2.86M in Q3 2021.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.